The DOI matches its Crossref record.
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
Open accessAbstract
OBJECTIVES: Clinical registries have shown their effectiveness in capturing the long-term benefit of drugs in routine care. In France, two types of registry have been established to analyse the safety and efficacy of biological agents. METHODS: The Research Axed on Tolerance of Biotherapies (RATIO) registry was designed to prospectively collect all cases of lymphoma and opportunistic infections occurring in patients receiving anti-TNF blockers for any indication. We also examined the results from nationwide prospective cohorts in order to investigate the safety and efficacy of rituximab (RTX), abatacept (ABA) and tocilizumab in RA and other autoimmune diseases. RESULTS: Analysis of the RATIO registry demonstrated an increased risk of Legionella pneumophila infection in patients receiving anti-TNF therapy, a higher risk of tuberculosis [odds ratio (OR) (95% CI): 13.3 (2.6, 69.0) and 17.1 (3.6, 80.6) for infliximab and adalimumab vs etanercept, respectively], opportunistic infections and incidence of lymphoma, with mAb than with soluble-receptor anti-TNF. The characteristics of RA patients in RTX and ABA registries showed that some patients did not receive previous TNF blockers [20% in autoimmunity and RTX (AIR) and 13% in Orencia and RA (ORA)] and one-third of them were treated without concomitant DMARDs. Patients receiving RTX showed an increased proportion of severe infections (5.0/100 patient-years). Lung and cardiac comorbidities, extra-articular involvement and low immunoglobulin G before RTX were predictive factors of severe infections. In addition, the AIR registry suggested the effectiveness of RTX in patients with SLE. CONCLUSION: The establishment of biological registries in rheumatic diseases, in France, with their different methods, has already provided additional data to controlled trials, mainly on the risk of severe infections and lymphoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review
Almutairi, K., Nossent, J., Preen, D., Keen, H., & Inderjeeth, C. (2021) · Rheumatology International · doi:10.1007/s00296-020-04731-0 · Cited by 753
Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
Roberts, D. M., Jones, R. B., Smith, R. M., Alberici, F., Kumaratne, D. S., Burns, S., & Jayne, D. R. W. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.11.009 · Cited by 301
Baillet, A., Gossec, L., Carmona, L., Wit, M. D., van Eijk-Hustings, Y., Bertheussen, H., Alison, K., Toft, M., Kouloumas, M., Ferreira, R. J. O., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209233 · Cited by 259
Metadata
- Authors
- Mariette, X., Gottenberg, J.-E., Ravaud, P., & Combe, B.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12-08
- Volume
- 50
- Issue
- 1
- Pages
- 222-229
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2141323245
- Cited by
- 173
- References
- 0
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. https://app.cochat.ai/papers/10.1093/rheumatology/keq368
- The paper
- Mariette, X., Gottenberg, J.-E., Ravaud, P., & Combe, B. (2011). Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology. https://doi.org/10.1093/rheumatology/keq368
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.